On July 23, 2025, Palisade Bio, Inc. entered into a warrant inducement agreement to reduce the exercise price of existing warrants to $0.9047 per share, potentially raising approximately $3.9 million in gross proceeds. The company will issue up to 4,318,905 new shares and seek stockholder approval for the transaction within 60 days.